Cdric Bossert - Compagnie Financire Group Counsel
Insider
Cdric Bossert is Group Counsel of Compagnie Financire Richemont
| Age | 64 |
| Phone | 41 22 721 3500 |
| Web | https://www.richemont.com |
Compagnie Financire Management Efficiency
The company has return on total asset (ROA) of 0.0655 % which means that it generated a profit of $0.0655 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1464 %, meaning that it generated $0.1464 on every $100 dollars invested by stockholders. Compagnie Financire's management efficiency ratios could be used to measure how well Compagnie Financire manages its routine affairs as well as how well it operates its assets and liabilities.Compagnie Financire Richemont has accumulated 9.05 B in total debt with debt to equity ratio (D/E) of 0.76, which is about average as compared to similar companies. Compagnie Financire has a current ratio of 2.37, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Compagnie Financire until it has trouble settling it off, either with new capital or with free cash flow. So, Compagnie Financire's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Compagnie Financire sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Compagnie to invest in growth at high rates of return. When we think about Compagnie Financire's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Gilles Andrier | Givaudan SA | 62 | |
| Alison Martin | Zurich Insurance Group | 49 | |
| Karen Hale | Novartis AG | 55 | |
| Kristof Terryn | Zurich Insurance Group | 56 | |
| Paul Penepent | Novartis AG | N/A | |
| Harry Kirsch | Novartis AG | 58 | |
| Laurent Pieren | Givaudan SA | N/A | |
| Tom Hallam | Givaudan SA | 57 | |
| MarieFrance Tschudin | Novartis AG | 52 | |
| Vasant Narasimhan | Novartis AG | 47 | |
| Klaus Moosmayer | Novartis AG | 55 | |
| Mario Greco | Zurich Insurance Group | 64 | |
| Robert PharmD | Novartis AG | 55 | |
| Louie DAmico | Givaudan SA | 62 | |
| Tulsi Naidu | Zurich Insurance Group | 50 | |
| Jeffrey Dailey | Zurich Insurance Group | 66 | |
| Sierra Signorelli | Zurich Insurance Group | 48 | |
| Hallvard Bremnes | Givaudan SA | N/A | |
| MBA BS | Zurich Insurance Group | 53 | |
| Anne Tayac | Givaudan SA | 55 | |
| Pierre Bnaich | Givaudan SA | N/A | |
Management Performance
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0655 |
Compagnie Financire Leadership Team
Elected by the shareholders, the Compagnie Financire's board of directors comprises two types of representatives: Compagnie Financire inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Compagnie. The board's role is to monitor Compagnie Financire's management team and ensure that shareholders' interests are well served. Compagnie Financire's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Compagnie Financire's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Eloy Michotte, Corp Director | ||
| Berangere Ruchat, Chief Officer | ||
| Jerome Lambert, Group Director | ||
| Cdric Bossert, Group Counsel | ||
| Patricia Gandji, Chief Regions | ||
| Johann Rupert, Founder Chairman | ||
| Sophie Cagnard, Head Director | ||
| Swen Grundmann, Company Sec | ||
| Riccardo Bellini, Chief Chlo | ||
| Burkhart Grund, CFO Director |
Compagnie Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Compagnie Financire a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0655 | |||
| Profit Margin | 0 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 69.72 B | |||
| Shares Outstanding | 515.24 M | |||
| Shares Owned By Institutions | 36.65 % | |||
| Price To Earning | 240.88 X | |||
| Price To Book | 3.93 X | |||
| Price To Sales | 3.24 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Compagnie Stock Analysis
When running Compagnie Financire's price analysis, check to measure Compagnie Financire's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compagnie Financire is operating at the current time. Most of Compagnie Financire's value examination focuses on studying past and present price action to predict the probability of Compagnie Financire's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compagnie Financire's price. Additionally, you may evaluate how the addition of Compagnie Financire to your portfolios can decrease your overall portfolio volatility.